FDA clears potential blockbuster diabetes drug from drugmakers Bristol-Myers and AstraZeneca

FDA approves new diabetes drug Onglyza

WASHINGTON — Federal health regulators on Friday approved a potential blockbuster diabetes drug from Bristol-Myers Squibb Co. and partner Astrazeneca PLC.

Full article »

Diabetes type2 drug FG- 3019 will be entering phase 2 clinical trial

four_peopleMedarex has intitiated phase 2 clinical trial of FG-3019 in patients with type 2 diabetes and advanced kidney disease. In this regard, Medarex will receive a milestone payment of an undisclosed amount from its licensing partner, FibroGen.

Full article »

Does diabetes type2 has its origin in your fats?

diabeticA Monash University study has proven a critical link between obesity and the onset of Type 2 diabetes, a discovery which could lead to the design of a drug to prevent the disease.

Full article »

Insulin Glargine found to be effective in restricting retinopathy

diabetic retinopathyA five year long research on insulin glargine and NPH treatment has been conducted in Sanofi-aventis, to observe the effectivity of these treatments in retinopathy which has been the major cause of blindness in diabetics. The study revealed glargine to be more effective than NPH.

Full article »

revolutionary drug Victoz can help obese type 2 diabetic reduce weight

obese-diabetic-on-scalesNew drug to help Type 2 diabetics lose weight being launched in UK

Full article »

How diabetes drugs raise heart failure risk

LONDON - A new study may help explain how a class of diabetes drugs increases the risk of heart failure.

Full article »

Diabetes drug along with diet, exercise promotes weight loss

WASHINGTON - A new study has shown that a commonly used diabetes drug in combination with diet and exercise helped nondiabetic, obese individuals lose over three times more weight.

Full article »

Popular diabetes drug can trigger pancreatic cancer

WASHINGTON - A drug widely used in the treatment of Type-2 diabetes may trigger low-grade pancreatitis in some patients and a greater risk of pancreatic cancer in long-term users.

Full article »

Popular diabetes drug can trigger pancreatitis, pancreatic cancer

WASHINGTON - A drug commonly used to treat type 2 diabetes has been found to increase the risk of pancreatitis in some patients and pancreatic cancer in long-term users, say researchers.

Full article »

Diabetes drugs may lead to vision-threatening complication

WASHINGTON - Treating diabetes with a class of drugs, called glitazone, leads to a “modest” increase in the risk of diabetic macular oedema (DME), which is a common vision-threatening complication, according to a study.

Full article »


Protected by Comment Guard Pro